PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.18%
Revenue growth above 1.5x AVGO's 7.09%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
15.77%
Gross profit growth under 50% of AVGO's 70.36%. Michael Burry would be concerned about a severe competitive disadvantage.
222.37%
EBIT growth above 1.5x AVGO's 73.63%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
222.37%
Operating income growth above 1.5x AVGO's 73.63%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
846.15%
Net income growth above 1.5x AVGO's 74.87%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
746.15%
EPS growth above 1.5x AVGO's 74.90%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
746.15%
Diluted EPS growth above 1.5x AVGO's 75.48%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.18%
Share reduction more than 1.5x AVGO's 1.02%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.62%
Diluted share count expanding well above AVGO's 0.96%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.18%
Dividend reduction while AVGO stands at 2.39%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
56.44%
Similar OCF growth to AVGO's 54.82%. Walter Schloss would assume comparable operations or industry factors.
71.22%
FCF growth 1.25-1.5x AVGO's 57.54%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
110.53%
10Y revenue/share CAGR under 50% of AVGO's 366.79%. Michael Burry would suspect a lasting competitive disadvantage.
64.71%
5Y revenue/share CAGR under 50% of AVGO's 290.65%. Michael Burry would suspect a significant competitive gap or product weakness.
24.45%
3Y revenue/share CAGR under 50% of AVGO's 268.76%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
185.38%
10Y OCF/share CAGR under 50% of AVGO's 767.35%. Michael Burry would worry about a persistent underperformance in cash creation.
28.02%
Below 50% of AVGO's 180.86%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
61.34%
3Y OCF/share CAGR under 50% of AVGO's 340.21%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
254.82%
Positive 10Y CAGR while AVGO is negative. John Neff might see a substantial advantage in bottom-line trajectory.
208.77%
Positive 5Y CAGR while AVGO is negative. John Neff might view this as a strong mid-term relative advantage.
35.10%
Positive short-term CAGR while AVGO is negative. John Neff would see a clear advantage in near-term profit trajectory.
211.42%
Equity/share CAGR of 211.42% while AVGO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
64.12%
Below 50% of AVGO's 546.89%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
8.56%
Below 50% of AVGO's 347.37%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.28%
AR growth is negative/stable vs. AVGO's 17.45%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-3.63%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.79%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.49%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
0.43%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
2.81%
R&D growth drastically higher vs. AVGO's 3.43%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
2.01%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.